In this research, the antimicrobial substance anti-JFL15 was partially purified using a simple two-step extraction process from the cell-free supernatants of Bacillus siamensis JFL15. Anti-JFL15 exhibited a strong antibacterial activity against various multidrug-resistant aquatic bacterial pathogens, including Escherichia coli, Edwardsiella tarda, Pseudomonas aeruginosa, Aeromonas hydrophila, and Vibrio. Liquid chromatography-mass spectrometry revealed that anti-JFL15 contained eight cyclic lipopeptides belonging to two families: bacillomycin F (m/z 1056.56-1084.59) and surfactin (m/z 1007.65-1049.70) analogs. PCR analysis showed the presence of genes (i.e., sfp gene, surfactin synthetase D, fengycin synthetase B, iturin synthetase A, iturin synthetase C and bacillomycin synthetase D) involved in the biosynthesis of cyclic lipopeptides. This study is the first to identify cyclic lipopeptides from B. siamensis and use them to suppress the growth of various multidrugresistant aquatic bacterial pathogens. Results indicated that B. siamensis JFL15 is a promising biocontrol agent for the effective and environmentally friendly control of various multidrug-resistant aquatic bacterial pathogens.
Introduction
Seafood safety concerns have increased in recent years with the increase in seafood consumption worldwide . In addition, the high demand of aquaculture has led to numerous disease outbreaks caused by various pathogens, resulting in serious economic losses (Gupta et al. 2016) . Vibrio, which causes acute gastroenteritis, is an important pathogen of reared aquatic organisms (Xu et al. 2013) . Antibiotic treatment of bacterial diseases in fish culture has been applied for many years (Guo et al. 2017) . However, the massive use of antibiotics encourages the natural emergence of antibiotic-resistant bacteria, which can transfer their resistance genes to other bacteria that have never been exposed to the antibiotics; this phenomenon exerts negative impacts on environment and human health (Ravindran et al. 2016) . The occurrence of antibiotic-resistant bacteria associated with fish diseases is a worsening worldwide problem in aquaculture because of the absence of effective and safe antibiotics (Kim et al. 2014) . Therefore, the development of effective and environmentally friendly alternative strategies for the control of aquatic pathogenic bacteria is highly important. Natural products with a broad spectrum of antibacterial activities, such as against multidrug-resistant pathogenic bacteria, are the best alternative to commercial antimicrobial substances.
The use of probiotics is an environmentally suitable alternative to prevent bacterial infections in aquaculture. Grampositive spore-forming Bacillus spp. are commonly used probiotics in aquaculture (Franco et al. 2017; Perez-Sanchez et al. 2014; Silva et al. 2012) . Bacillus can form spores and thus can tolerate the harsh conditions, such as acidic and bile environment, of the animal gastrointestinal tract when administered as a diet additive . Species Ben-Hong Xu and Zhi-Wei Ye contributed equally to this work. from this genus can also produce more than 20 types of antimicrobial compounds (Stein 2005; Sumi et al. 2015) . Gene sequencing has revealed that more than 4% of the genes in the genome of Bacillus are involved in the production of antimicrobial compounds (Baltz 2017) . Generally, antimicrobial substances are formed through ribosomal or nonribosomal synthesis. Those substances formed by ribosomal synthesis include antimicrobial proteins (Zhao et al. 2016) , bacteriocin (Lim et al. 2011) , bacteriocin-like inhibitory substance (Abriouel et al. 2011) , and subtilin (Barbosa et al. 2015) , whereas those formed by nonribosomal peptide synthetases (Niazi et al. 2014 ) and polyketide synthases (Baltz 2017) include cyclic lipopeptides (CLPs) from the surfactin, iturin, and fengycin families and polyketides from the bacillaene, difficidin, and microlactin families, respectively. Among these antimicrobial substances, CLPs produced by Bacillus have received increasing attention because of their stronger biological activities, including wide-spectrum antimicrobial, antitumor, antimycoplasma, and antiviral activities, and greater thermostability and resistance to degradation by proteolytic enzymes (Lee et al. 2016 ) when compared with other ribosomally synthesized antimicrobial compounds. These CLPs also cause less bacterial resistance compared with traditional antibiotics (Chen et al. 2017) . These substances have a common amphipathic structure with a hydrophilic peptide portion and a hydrophobic fatty acid portion (Ramarathnam et al. 2007) . In recent years, many scholars have investigated the antagonistic activities of CLPs against aquatic pathogens. Xu et al. (2014) determined that the CLPs produced by Bacillus amyloliquefaciens M1 showed strong antimicrobial properties against multidrugresistant Vibrio spp. isolated from diseased marine animals. Xiu et al. (2017) illustrated that CLPs from Bacillus sp. 176 exhibited antimicrobial activity against Vibrio alginolyticus 178 by significantly suppressing its motility. CLPs have been applied in many fields, such as agriculture, medicine, food, and environmental protection, and have received increasing attention as promising new antibiotic candidates (Lee et al. 2016) . However, the lack of sources and the high production cost of CLPs limit their commercial application. In biotechnological processes, the downstream processing of CLPs is responsible for 60% of the total cost of the product because their purification require multiple steps involving salt precipitation followed by various combinations of ion-exchange, reverse-phase, affinity, and gel-exclusion chromatography (Touraki et al. 2012; Lee et al. 2016) . In recent decades, numerous efforts in the bioprocess engineering field have been devoted to improving CLP production; these efforts included increasing productivity by using mutant strains and simplifying downstream processing by developing integrative processes (Jauregi et al. 2013) .
In the present research, we identified and characterized the antimicrobial compounds produced by B. siamensis JFL15. The antimicrobial compounds exhibited stronger antimicrobial activity and broader antimicrobial spectrum than nisin and polymyxin B against fish pathogens with multidrug-resistant profiles. HPLC-MS analysis revealed that the antimicrobial substances are composed of multiple CLPs of the bacillomycin and surfactin families. The antibacterial effects and mechanisms of anti-JFL15 were further evaluated. The two-step separation and purification methods used in this research can provide a reference for the large-scale and efficient preparation of other antimicrobial compounds. Results suggested that B. siamensis JFL15 could be used as an environmentally friendly agent for the control of fish pathogens. To the best of our knowledge, this study is the first to purify and identify CLPs against various multidrug-resistant aquatic bacterial pathogens from Bacillus siamensis.
Materials and methods

Bacterial strains and culture conditions
Bacillus siamensis JFL15, which exhibits antimicrobial activity to a number of multidrug-resistant aquatic bacterial pathogens, was isolated from the gastrointestinal tract of hairtail and the genome sequenced (GenBank genome accession number LFWQ00000000). The indicator bacteria applied in this study were provided by Professor Zaiguang Fang of Hainan University Institute of Marine (Hainan, China). The indicator fungi Magnaporthe grisea and Rhizoctonia solani were provided by Professor Erxun Zhou at South China Agricultural University (Guangzhou, China), and the indicator fungi Colletotrichum gloeosporioides and Peronophythora litchii were from the laboratory storage. Luria-Bertani (LB) broth medium (containing 10 g/L tryptone, 5 g/L yeast extract, and 5 g/L NaCl in distilled water) was used as the growth medium for the strain JFL15 and indicator bacteria, and mineral salt medium (MSM) (containing 20 g/L sucrose, 2 g/L NH 4 NO 3 , 3 g/L KH 2 PO 4 , 10 g/L Na 2 HPO 4 , 0.2 g/L MgSO 4 , 0.2 g/L yeast extract, 0.7 µg/L CaCl 2 , and 1 µg/L MnSO 4 in distilled water) was used for the production of antimicrobial compounds by culturing at 30 °C for 3 days with continuous shaking at 200 rpm. The indicator of pathogenic fungi was incubated on a PDA plate at 28 °C for 7 days.
Measurement of drug resistance of fish pathogens
Fifteen indicator bacteria were aerobically cultivated overnight in an LB liquid medium at 37 °C for 24 h. Sterile Oxford cups (6 × 10 mm) were placed on LB plates seeded with the different bacterial cultures. Each cup was added with 150 µL of commonly used antibiotics (100 µg/mL) ( Table 2 ) and then incubated overnight at 37 °C. The clear zones around the Oxford cups were observed. All experiments were conducted in triplicate.
Production and partial purification of antimicrobial substance from JFL15
The strain JFL15 was incubated in MSM medium for the production of CLPs at 180 rpm and 30 °C for 72 h. The cell-free supernatant was obtained by centrifuging the cultures at 8000×g for 20 min, and the antimicrobial substance was concentrated through ammonium sulfate precipitation at 4 °C storage overnight. The cultured supernatant was then precipitated by different concentrations of ammonium sulfate (10-80%), and the antimicrobial activities of these precipitates were examined to identify the concentration of ammonium sulfate with the highest activity. The precipitate was collected by centrifugation (8000×g, 10 min) at 4 °C, and crude lipopeptide was obtained by vacuum freeze drying before extraction with phosphate-buffered saline (PBS, pH 7.4) for four times. The insoluble precipitate was extracted with methanol thrice to obtain the last residual antimicrobial substance. The methanol extract was concentrated using a rotary evaporator under reduced pressure, and the partially purified antimicrobial substance from B. siamensis JFL15 was designated anti-JFL15. 
Determination of antimicrobial activity of anti-JFL15
The antimicrobial activity of anti-JFL15 was determined by using the Oxford cup method (Moyne et al. 2001) : hyphae discs of phytopathogens (M. grisea, R. solani, and C. gloeosporioides) were placed in the center of each PDA plate with the sterilized Oxford cup, which was 3 cm away from the edge of the mycelial colony. Anti-JFL15 (150 µL) was then added into the Oxford cup and then incubated at 28 °C for 7 days. The antifungal effect of anti-JFL15 was determined based on the semidiameter of the inhibition zone.
For the analysis of antibacterial activity, 30 µL of indicator bacteria was mixed with 30 mL of LB broth, which was cooled to approximately 55 °C and poured into sterile plates placed with sterile Oxford cups in advance. When the plates solidified, the Oxford cups were removed, and 150 µL of anti-JFL15 was added into the hole. The plates were incubated overnight at 37 °C, and the diameter of the clear zone was used as a measure of antibacterial activity. The same volume of methanol was used as control in all antimicrobial experiments. The zones of inhibition were manually measured with accuracy ± 1 mm. All experiments were conducted in triplicate.
PCR amplification of lipopeptide biosynthetic genes from genomic DNA
Total genomic DNA was extracted from JFL15 using the TIANamp Bacteria DNA Kit [Tiangen Biotech (Beijing) Co., Ltd.] in accordance with the manufacturer's instructions. Lipopeptide biosynthetic genes, namely surfactin (sfp and srfD), iturin (ituA and ituC), bacillomycin (bmyA), and fengycin (fenB) were identified in the genome sequence of B. siamensis JFL15, primers synthesized and the genes detected in the genomic DNA extract using PCR. PCR was conducted in 50-µL volumes with varying annealing temperatures and times for each specific primer (Table 1) in PCR amplifier (BIORAD, USA).
LC-MS/MS analysis
LC-MS analysis was performed to identify the partially purified bioactive substance anti-JFL15. The substance was separated using UHPLC on an Agilent system equipped with a C18 column (250 mm × 4.6 mm, 5 µm, Agilent, USA). The mobile phase consisted of solvent A (acetonitrile) and solvent B (0.1% formic acid in water). A linear gradient was used for elution at a flow rate of 1 mL/min as follows: 0-30 min, from 10 to 50% B (linear gradient); 30-50 min, from 50 to 93% B (linear gradient); and 50-70 min, 93% B (isocratic). Elution was monitored by determining absorbance at 214 nm. The column temperature was 28 °C, and the injection volume was 2 µL. The peaks were then analyzed in two (positive and negative) ion modes from m/z 200 to 2000 using quadrupole time-of-flight mass spectrometry (Q-TOF-MS) (Agilent Technologies 6540B, USA). The Q-TOF-MS system was equipped with an ESI interface, a collision cell, and two mass analyzers. The operating parameters included a capillary voltage of 800 V, a cone voltage of 40 V, a fragmentor voltage of 175 V, and a capillary temperature of 27 °C.
Statistical analysis
Data were collected from three independent experiments and expressed as the mean ± standard deviation of three replicates. Statistical analysis was performed using ANOVA in SPSS 19.0 software. Statistical significance was considered at P < 0.05 or < 0.01.
Results
Measurement of drug resistance of the fish pathogens
To determine the resistance of fish pathogens to common antibiotics, the effects of different antibiotics on the growth of fish pathogens were examined. As shown in Table 2 , all fish pathogens used in this study were resistant to different antibiotics. Pseudomonas aeruginosa was resistant to all six antibiotics, suggesting that all fish pathogens in this study are multidrug-resistant strains.
PCR amplification of lipopeptide biosynthetic genes from genomic DNA
All mentioned PCR products, such sfp (surfactin regulatory gene), srfD (surfactin synthetase D), fenB (fengycin synthetase B), ituA (iturin synthetase A), ituC (iturin synthetase C), and bamD (bacillomycin synthetase D), were amplified with PCR. Results showed that all products exhibited a single thick band that was the size of the expected product (Fig. 1) . The presence of all these genes in B. siamensis JFL15 facilitated the production of various CLPs, such as surfactin, fengycin, iturin, and bacillomycin.
Production and partial purification of antimicrobial substance
For mass production of the antimicrobial substance, B. siamensis JFL15 was incubated in 5 L of MSM medium at 30 °C for 3 days, and the cell-free supernatant was concentrated using the ammonium sulfate precipitation method.
All components of ammonium sulfate precipitation demonstrated antibacterial activity against the multidrug-resistant Aeromonas hydrophila, and the antibacterial activity increased with the rise of ammonium sulfate saturation. The largest antibacterial activity was obtained when the saturation of ammonium sulfate reached 60%, which was the optimal concentration for the purification of the bioactive substance (Fig. 2) . Results indicated that 60% saturation of ammonium sulfate could precipitate most of the antimicrobial substances in the cell-free supernatant.
The precipitate was extracted by a simple two-step purification process. CLPs such as surfactin, iturin, and fengycin are common amphipathic compounds. Therefore, the concentrated substance was extracted by PBS buffer solution (pH 7.4) for four times, and the insoluble precipitate was extracted by methanol to obtain the last residual antimicrobial substance (anti-JFL15). This two-step extraction-purification process significantly improved the purity of anti-JFL15, which only contained two clusters of peaks: the first between 28.49 and 34.68 min and the second between 60.54 and 63.35 min. Anti-JFL15 exhibited strong antibacterial and antifungal activities against A. hydrophila and C. gloeosporioides, respectively (Fig. 3) .
LC-MS/MS analysis CLPs
Comprehensive MS analysis of anti-JFL15 revealed the presence of two types of CLPs belonging to the bacillomycin and surfactin families. The protonated molecular ion [M+H] + weights of the bacillomycin and surfactin families ranged from m/z 1057.57 to 1085.59 and m/z 1008.65 to 1050.71, respectively (Table 3 ). All molecules within each family had a 14 Da difference in molecular weight, suggesting that several lipopeptide analogs containing distinct lengths of fatty acid chains (CH 2 = 14 Da) were present in anti-JFL15.
The fragmentation data of the specific masses based on LC-MS/MS were analyzed to determine the presence of the fingerprint masses of each compound related to a structure previously reported. Comparison of the high-resolution mass and MS/MS spectral characteristics with published data revealed that two types of CLPs with strong antimicrobial activity were identical to bacillomycin F and surfactin. In this study, component 7 (Table 3) (Fig. 4) . In comparison with literature data, results illustrate that the substance with a molecular weight at m/z 1036.69 is C 15 surfactin Jasim et al. 2016) .
Inhibitory spectrum of anti-JFL15
The inhibition spectrum of anti-JFL15 against various bacteria and fungi was determined using the agar disk diffusion method. The antimicrobial activity of anti-JFL15 was compared with those of commercially available nisin and polymyxin B (Sigma), which served as bacteriocin and lipopeptide representatives, respectively (Table 4 ). Nisin did not inhibit the growth of Gram-negative and fungi indicators, whereas polymyxin B inhibited only Gram-negative bacteria. The bioactive substances of anti-JFL15 inhibited all indicators, including Gram-negative bacteria and fungi. The antibacterial activity of anti-JFL15 against Gramnegative bacteria was stronger than that of polymyxin B. These results suggested that anti-JFL15 has a strong and wide spectrum of antimicrobial activity against multidrugresistant fish pathogens.
Discussion
Severe water pollution with the rapid development of largescale intensive aquaculture over the past few years has caused various aquatic animal disease outbreaks. These outbreaks have restricted the healthy development of the aquaculture industry by causing economic losses and food safety concerns (Zhang et al. 2014 ). According to the recent report by the Center for Disease Control and Prevention Food-borne Surveillance Network (FoodNet), more than 24,000 people in 2016 were affected by food-borne illnesses mainly caused by E. coli, Edwardsiella tarda, P. aeruginosa, A. hydrophila, and Vibrio (Abdullah et al. 2017) . To avoid such high economic losses in fish, several veterinary drugs are applied in aquaculture to prevent or treat disease outbreaks. However, the application of antibiotics and chemotherapeutics to control these diseases causes the rapid development of multidrug-resistant pathogens, which pose risks to the environment and consumers. Table 2 shows that all the bacterial pathogens used in this research are multidrugresistant strains, which are consistent with the experimental results of Xu et al. (2014) . Within Vibrionaceae, more than 50% of the 134 isolates that were examined showed multidrug resistance to several different antibiotics, including . In addition, out of the 56 isolates of A. hydrophila that were examined, five showed a high frequency of multiple (20) drug resistance (Ali et al. 2016) . Therefore, alternatives for antibiotics should immediately be discovered with the increasing demand for environmentally friendly aquaculture. These CLPs, which are the main CLP families in Bacillus, have a common amphipathic structure with a hydrophilic peptide portion and a hydrophobic fatty acid portion. Screening for the presence of biosynthetic genes is essential for identifying organisms with biosynthetic potential and targeting compounds responsible for the bioactivity. Active compounds can then be easily identified and purified with the presence of these biosynthetic genes.
The cell-free supernatant was concentrated by ammonium sulfate precipitation. As shown in Fig. 2 , the antibacterial activity varied with ammonium sulfate saturation. One reason for this finding is that Bacillus can produce a variety of antibacterial substances, such as ribosomal antibiotics (e.g., bacteriocin, antibacterial peptide, and antibacterial protein) and nonribosomal antibiotics (e.g., CLPs and polyketides) (Sumi et al. 2015 ). Another reason is that different concentrations of ammonium sulfate can precipitate different antibacterial active substances. For example, An et al. (2015) suggested the purification of a novel bacteriocin CAMT2 by ammonium sulfate precipitation at 60% saturation. In addition, Shi et al. (2015) have successfully purified a thermostable antibacterial protein from B. subtilis FB123 using 50% saturated ammonium sulfate. Meanwhile, Lee et al. (2016) have purified two types of antimicrobial lipopeptides, bacillomycin and surfactin, by using 80% saturation of ammonium sulfate.
As biosurfactants, CLPs are amphipathic molecules with hydrophilic and hydrophobic moieties. The precipitate was purified by a simple two-step extraction process (PBS and methanol), which substantial increased the purity of anti-JFL15 that only contained two clusters of peaks (Fig. 3) . A possible reason for this result may be most of the water-soluble impurities are dissolved in PBS. The two-step extraction method can be applied to purify CLPs or other antimicrobial substances to save time, effort, and cost relative to the traditional downstream extraction process, which is laborious, provides low yields, and takes up 60% of the total cost of the product. Different from our two-step extraction method, the traditional extraction process requires multiple steps involving salt precipitation followed by various combinations of ion-exchange, reverse-phase, affinity, gel-exclusion chromatography, and HPLC.
ESI-CID-MS/MS analyses indicated that the CLP was broken and therefore generate a series of specific b-and y-type ion fragments, which can be observed as a "fingerprint" of the MS/MS spectrum of a unique compound. For example, C 15 surfactin was identified by the typical b-and y-type fragment ions generated by broken precursor ions [M+H] + (m/z 1036.69) at m/z 370. 2, 483.3, 596.4, 695.5, 923.6 and 227.2, 352.2, 441.2, 554.4, 685.4, respectively (Fig. 4) . These results are consistent with the mass fragments reported in a previous study (Pathak and Keharia 2014) . As shown in Fig. 3 , anti-JFL15 exhibited high antibacterial and antifungal activities mainly because surfactin has strong antibacterial activity and bacillomycins (D, F, L, and LC) have significant antifungal activities (Zhang et al. 2013 ). In addition, distinct lipopeptide families co-produced by a single strain exert a synergistic effect and mutually enhance their respective activities. For example, the antifungal activity of bacillomycin D against gray mold disease is stimulated by surfactin homologs produced by the same strain of B. amyloliquefaciens SD-32 (Tanaka et al. 2015) . Thus, anti-JFL15 may potentially be used in some biotechnological industries because it contains a heterogeneous lipopeptide mixture comprising eight species from two CLP families. Moreover, the commercial surfactin standard (purity: ≥ 98%, Sigma) contains four homologs (C 12 -C 15 ) (Lee et al. 2016) and no bacillomycin F standard is on the market. So, anti-JFL15 can be further used to produce commercial surfactin and bacillomycin F standard by HPLC purification. As shown in Fig. 1, B . siamensis JFL15 can produce three types of CLPs (surfactin, fengycin and iturin), but only surfactin and iturin were identified in anti-JFL15. This result can be attributed to the fact that at least six fengycin homologs were identified in the PBS extraction component by their strong water solubility (data not shown).
Many Bacillus species, such as B. subtilis, B. amyloliquefaciens, B. licheniformis, B. pumilus, and B. mojavensis, have been used as probiotics in aquaculture due to their strong antibacterial activities against various multidrug-resistant aquatic bacterial pathogens Chakraborty et al. 2017a, b; Chen et al. 2017; Cheng et al. 2017) . However, only a few studies have reported the use of B. siamensis in aquaculture (Meidong et al. 2017) . CLPs have been previously characterized from Bacillus, such as Bacillus subtilis (Farace et al. 2015) and Bacillus amyloliquefaciens (Kim et al. 2017) , but this study is the first to purify and identify CLPs from the species of B. siamensis and use them to suppress the growth of various multidrug-resistant aquatic bacterial pathogens.
In conclusion, the antimicrobial substance (named anti-JFL15) from cell-free supernatants of B. siamensis JFL15 was partially purified using a simple two-step extraction process, i.e., PBS and methanol extraction after ammonium sulfate precipitation at 60% saturation, which saved time, effort, and cost. Anti-JFL15 exhibited a stronger and wider spectrum of antimicrobial activity than commercially available nisin and polymyxin B. Moreover, anti-JFL15 was identified as a lipopeptide mixture of four bacillomycin F and four surfactin analogs, which may potentially be used in some biotechnological industries, such as aquaculture protection, environmental bioremediation, pharmaceuticals, and cosmetics. These results indicated that B. siamensis JFL15 was a promising biocontrol agent for an effective and environmentally friendly control of various multidrug-resistant aquatic bacterial pathogens. Future studies will focus on other antibacterial mechanisms of anti-JFL15 against aquatic bacterial pathogens and apply proteomics and transcriptomics methods to investigate the signaling pathways involved in the antibacterial effects.
